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anglais
BACKGROUND: Episodic Angioedema with eosinophilia (EAE, Gleich's syndrome) is
a rare disorder consisting of recurrent episodes of angioedema, hypereosinophilia
and frequent elevated serum Immunoglobin M.
METHODS: We conducted a retrospective multicenter nationwide study regarding
the clinical spectrum and therapeutic management of patients with EAE in France.
RESULTS: Thirty patients were included with a median age at diagnosis of 41 years
[5-84]. The median duration of each crisis was 5.5 days [1-90] with swelling
affecting mainly the face and the upper limbs. Total serum IgM levels were
increased in 20 patients (67%). Abnormal T-cell immunophenotypes were detected
in 12 patients (40%) among which 5 (17%) showed evidence of clonal TCR γ gene
rearrangement. Median follow-up duration was 53 months [31-99]. The presence of
an abnormal T-cell population was the sole factor associated with a shorter time to
flare (hazard ratio 4.15 [CI 95% 1.18-14.66; p=0.02). At last follow-up, 3 patients
(10%) were able to withdraw all treatments and 11 (37%) were in clinical and
biological remission with less than 10 mg of daily prednisone.
CONCLUSION: EAE is a heterogeneous condition that encompasses several disease
forms. Although patients usually respond well to glucocorticoids, those with
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